T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Fluence Energy
FLNC
$1.09B
| $2.32M | ﹤0.01% |
116,787
-1,489,027
| -93% | -$27.7M |
|
1927
Sanofi
SNY
$98.4B
| $2.32M | ﹤0.01% |
54,377
-1,558,998
| -97% | -$69.7M |
|
1928
FIVE9
FIVN
$2.58B
| $2.31M | ﹤0.01% |
108,418
+14,541
| +15% | +$287K |
|
1929
Community Trust Bancorp
CTBI
$1.37B
| $2.31M | ﹤0.01% |
31,856
+5,688
| +22% | +$379K |
|
1930
NWPX Infrastructure Inc
NWPX
$989M
| $2.29M | ﹤0.01% |
15,273
+2,808
| +23% | +$307K |
|
1931
SELLAS Life Sciences
SLS
$2.35B
| $2.29M | ﹤0.01% |
155,066
+32,946
| +27% | +$227K |
|
|
BBOT
1932
BridgeBio Oncology
BBOT
$310M
| $2.29M | ﹤0.01% |
300,000
-137,889
| -31% | -$1.15M |
|
1933
Origin Bancorp
OBK
$1.65B
| $2.28M | ﹤0.01% |
44,645
+8,267
| +23% | +$389K |
|
1934
Arrow Financial
AROW
$698M
| $2.28M | ﹤0.01% |
55,668
+7,682
| +16% | +$285K |
|
1935
MillerKnoll
MLKN
$1.39B
| $2.28M | ﹤0.01% |
111,363
+14,863
| +15% | +$238K |
|
1936
Gibraltar Industries
ROCK
$1.21B
| $2.28M | ﹤0.01% |
50,504
+7,965
| +19% | +$312K |
|
1937
Kemper
KMPR
$1.5B
| $2.27M | ﹤0.01% |
84,365
+22,698
| +37% | +$661K |
|
1938
Worthington Enterprises
WOR
$2.96B
| $2.27M | ﹤0.01% |
42,317
+5,778
| +16% | +$322K |
|
1939
Intapp
INTA
$2.69B
| $2.27M | ﹤0.01% |
90,151
-516,331
| -85% | -$11.8M |
|
1940
TETRA Technologies
TTI
$899M
| $2.26M | ﹤0.01% |
199,806
+35,667
| +22% | +$349K |
|
1941
Astec Industries
ASTE
$946M
| $2.24M | ﹤0.01% |
36,604
+6,026
| +20% | +$333K |
|
1942
Atlas Energy Solutions
AESI
$1.55B
| $2.24M | ﹤0.01% |
134,682
+24,766
| +23% | +$405K |
|
1943
Safety Insurance
SAFT
$1.52B
| $2.23M | ﹤0.01% |
29,799
+4,571
| +18% | +$333K |
|
1944
Centuri Holdings
CTRI
$2.03B
| $2.23M | ﹤0.01% |
73,692
+10,945
| +17% | +$353K |
|
1945
Kiniksa Pharmaceuticals
KNSA
$5.87B
| $2.23M | ﹤0.01% |
+34,830
| New | +$1.81M |
|
|
MANE
1946
Veradermics Inc
MANE
$4.83B
| $2.23M | ﹤0.01% |
+18,114
| New | +$1.7M |
|
1947
Capitol Federal Financial
CFFN
$1.05B
| $2.22M | ﹤0.01% |
260,681
+37,284
| +17% | +$291K |
|
|
MPT
1948
Medical Properties Trust
MPT
$2.11B
| $2.21M | ﹤0.01% |
478,444
+26,553
| +6% | +$132K |
|
1949
CBIZ
CBZ
$3.01B
| $2.21M | ﹤0.01% |
68,871
+9,523
| +16% | +$296K |
|
1950
Healthcare Services Group
HCSG
$1.43B
| $2.21M | ﹤0.01% |
89,817
+12,255
| +16% | +$259K |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.